Intra-arterial tissue plasminogen activator: An effective adjunct following microsurgical venous thrombosis

Annals of Plastic Surgery

Volumn 59, Issue 5, 2007, Pages 520-525

  Casey III, William J ^a   Craft, Randall O ^a   Rebecca, Alanna M ^a   Smith, Anthony A ^a   Yoon, Sung ^a  

^a MAYO CLINIC   (United States)

Author keywords

Tissue plasminogen activator; Venous thrombosis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANASTOMOSIS; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; FREE TISSUE GRAFT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MICROSURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VEIN ANASTOMOSIS; VEIN GRAFT; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ARTERIES; FEMALE; HUMANS; MAMMAPLASTY; MICROSURGERY; MIDDLE AGED; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SKIN TRANSPLANTATION; SURGICAL FLAPS; TISSUE PLASMINOGEN ACTIVATOR; VENOUS THROMBOSIS;

EID: 40349116155     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000258971.73613.65     Document Type: Article

References (33)

1. th Annual Convention of the American Society of Plastic and Reconstructive Surgeons. 1981;4:93.
2. Khouri RK, Cooley BC, Kunselman AR, et al. A prospective study of microvascular free-flap surgery and outcome. Plast Reconstr Surg. 1998;102:711-721.
3. Gill PS, Hunt JP, Guerra AB, et al. A 10-year retrospective review of 758 DIEP flaps for breast reconstruction. Plast Reconstr Surg. 2004; 113:1153-1160.
4. Lidman D, Daniel RK. Evaluation of clinical microvascular anastomoses: reasons for failure. Ann Plast Surg. 1981;6:215-223.
5. Kroll SS, Schusterman MA, Reece GP, et al. Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg. 1996; 98:1230-1233.
6. Goldberg JA, Pederson WC, Barwick WJ. Salvage of free tissue transfers using thrombolytic agents. J Reconstr Microsurg. 1989;5:351-356.
7. Serletti JM, Moran SL, Orlando GS, et al. Urokinase protocol for free-flap salvage following prolonged venous thrombosis. Plast Reconstr Surg. 1998;102:1947-1953.
8. Yii NW, Evans GR, Miller MJ, et al. Thrombolytic therapy: what is its role in free flap salvage? Ann Plast Surg. 2001;46:601-604.
9. Maginot TJ, Sadove AM, Jones C. Comparison of urokinase and tissue plasminogen activator for thrombolysis in rats. Invest Radiol. 1991;26: 46-49.
10. Cooley BC, Jones MM, Dellon AL. Comparison of efficacy of Thrombolysin, streptokinase, and urokinase in a femoral vein clot model in rats. Microsurgery. 1983;4:1-4.
11. Rohrich RJ, Handren J, Kersh R, et al. Prevention of microvascular thrombosis with short-term infusion of human tissue-type plasminogen activator. Plast Reconstr Surg. 1996;98:118-128.
12. Arnljots B, Wieslander JB, Dougan P, et al. Prevention of microvascular thrombosis with low-dose tissue plasminogen activator. Plast Reconstr Surg. 1992;90:281-288.
13. Hergrueter CA, Handren J, Kersh R, et al. Human recombinant tissue type plasminogen activator and its effect on microvascular thrombosis in the rabbit. Plast Reconstr Surg. 1988;81:418-424.
14. Lykoudis EG, Contodimos GB, Tsoutsos DA, et al. Microsurgical repair after crush-avulsion injury of the femoral vein in rats: prevention of microvascular thrombosis with recombinant human tissue-type plasminogen activator (rt-PA). Microsurgery. 2001;21:357-361.
15. Lykoudis EG, Panayotou PN, Stamatopoulos CN, et al. Microvascular repair following a modified crush-avulsion injury in a rat model: effect of recombinant human tissue-type plasminogen activator on the patency rate. Microsurgery. 2000;20:52-58.
16. Hirigoyen MB, Prabhat A, Zhang WX, et al. Improved efficacy of urokinase further prolongs ischemic skin-flap survival. J Reconstr Microsurg. 1995;11:151-155.
17. Israeli D, Zhang WX, Senderoff DM, et al. Use of urokinase during secondary ischemia in experimental skin flaps. Ann Plast Surg. 1994; 32:305-309.
18. Senderoff DM, Zhang WX, Israeli D, et al. The additive beneficial effect of UW solution and urokinase on experimental microvascular free-flap survival. J Reconstr Microsurg. 1993;9:197-201.
19. Schubert W, Hunter DW, Guzman-Stein G, et al. Use of streptokinase for the salvage of a free flap: case report and review of the use of thrombolytic therapy. Microsurgery. 1987;8:117-121.
20. Lipton HA, Jupiter JB. Streptokinase salvage of a free-tissue transfer: case report and review of the literature. Plast Reconstr Surg. 1987;79: 977-981.
21. Fudem GM, Walton RL. Microvascular thrombolysis to salvage a free flap using human recombinant tissue plasminogen activator. J Reconstr Microsurg. 1989;5:231-234.
22. Loscalzo J, Braunwald E. Tissue plasminogen activator. N Engl J Med. 1988;319:925-931.
23. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial: phase I findings. N Engl J Med. 1985;312:932-936.
24. Graor RA, Comerota AJ, Douville Y, et al. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremities (the STILE Trial). Ann Surg. 1994;220:251-266.
25. Collen D. On the regulation and control of fibrinolysis. Thromb Haemost. 1980;43:77-89.
26. Collen D, Stump DC, Gold HK. Thrombolytic therapy. Ann Rev Med. 1988;39:405-423.
27. Hidalgo DA, Disa JJ, Cordeiro PG, et al. A review of 716 consecutive free flaps for oncologic surgical defects: refinement in donor-site selection and technique. Plast Reconstr Surg. 1998;102:722-732.
28. Wilson EL, Becker ML, Hoal EG, et al. Molecular species of plaminogen activators secreted by normal and neoplastic human cells. Cancer Res. 1980;40:933-938.
29. Eisenberg PR, Sherman LA, Tiefenbrunn AJ, et al. Sustained fibrinolysis after administration of t-PA despite its short half-life in the circulation. Thromb Haemost. 1987;57:35-40.
30. Matsuo O, Rijken DC, Collen D. Comparison of the relative fibrinogenolytic, fibrinolytic, and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Thromb Haemost. 1981;45:225-229.
31. Stassen JM, Lu G, Andreen O, et al. Intraoperative thrombolytic treatment of microarterial occlusion by selective rt-PA infusion. Plast Reconstr Surg. 1995;96:1215-1217.
32. Atiyeh BS, Hashim HA, Hamdan AM, et al. Local recombinant tissue plasminogen activator (rt-PA) thrombolytic therapy in microvascular surgery. Microsurgery. 1999;19:265-271.
33. Bonde CT, Heslet L, Jansen E, et al. Salvage of free flaps after venous thrombosis: case report. Microsurgery. 2004;24:298-301.